Apbiocode
1 known investors
Applied BioCode develops high-throughput molecular diagnostic systems and syndromic panels for detecting infectious disease pathogens, using a 96-well format instrument that can process up to 188 samples per shift and run multiple panels in parallel. Its BioCode products serve clinical molecular diagnostics and research laboratories, with data-masking capabilities aligned to MolDX reimbursement standards.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Apbiocode do?
- Applied BioCode develops high-throughput molecular diagnostic systems and syndromic panels for detecting infectious disease pathogens, using a 96-well format instrument that can process up to 188 samples per shift and run multiple panels in parallel. Its BioCode products serve clinical molecular diagnostics and research laboratories, with data-masking capabilities aligned to MolDX reimbursement standards.
- Who are Apbiocode's investors?
- Apbiocode's investors include GRC Sinogreen.